GW&K Investment Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.3M Buy
354,966
+104,608
+42% +$1.89M 0.07% 263
2025
Q4
$3.55M Buy
250,358
+20,376
+9% +$386K 0.03% 285
2025
Q3
$5.69M Sell
229,982
-1,349,272
-85% -$30.1M 0.05% 264
2025
Q2
$35.8M Buy
1,579,254
+585,613
+59% +$13.9M 0.32% 122
2025
Q1
$30.1M Buy
993,641
+7,155
+0.7% +$273K 0.28% 146
2024
Q4
$39.1M Sell
986,486
-20,795
-2% -$938K 0.33% 118
2024
Q3
$63.9M Buy
1,007,281
+205,991
+26% +$14.9M 0.55% 54
2024
Q2
$54.1M Buy
801,290
+25,120
+3% +$1.75M 0.49% 71
2024
Q1
$61.5M Sell
776,170
-14,551
-2% -$1.19M 0.54% 58
2023
Q4
$61.5M Sell
790,721
-22,997
-3% -$1.7M 0.57% 52
2023
Q3
$57.2M Sell
813,718
-26,527
-3% -$1.98M 0.57% 52
2023
Q2
$66.9M Buy
840,245
+12,752
+2% +$922K 0.63% 41
2023
Q1
$59.8M Buy
827,493
+34,410
+4% +$2.68M 0.58% 55
2022
Q4
$65.3M Sell
793,083
-9,633
-1% -$794K 0.66% 32
2022
Q3
$62.8M Sell
802,716
-61,630
-7% -$4.93M 0.69% 34
2022
Q2
$58.5M Sell
864,346
-415,550
-32% -$29M 0.63% 41
2022
Q1
$83.9M Sell
1,279,896
-230,091
-15% -$13.4M 0.75% 25
2021
Q4
$91.7M Buy
1,509,987
+62,497
+4% +$3.73M 0.77% 25
2021
Q3
$92.3M Sell
1,447,490
-13,931
-1% -$879K 0.82% 20
2021
Q2
$91.7M Buy
1,461,421
+16,560
+1% +$1.04M 0.8% 19
2021
Q1
$82.6M Buy
1,444,861
+202,576
+16% +$11M 0.76% 23
2020
Q4
$62.4M Buy
1,242,285
+482,313
+63% +$19.2M 0.66% 27
2020
Q3
$22.4M Buy
759,972
+9,833
+1% +$285K 0.29% 148
2020
Q2
$18.8M Buy
750,139
+4,950
+0.7% +$124K 0.26% 165
2020
Q1
$13.7M Buy
745,189
+33,393
+5% +$956K 0.24% 161
2019
Q4
$23.6M Sell
711,796
-27,997
-4% -$877K 0.32% 142
2019
Q3
$23M Buy
739,793
+107,577
+17% +$3.28M 0.32% 138
2019
Q2
$22.1M Buy
632,216
+151,737
+32% +$4.91M 0.34% 131
2019
Q1
$14.1M Buy
480,479
+3,850
+0.8% +$109K 0.23% 176
2018
Q4
$12.3M Sell
476,629
-6,506
-1% -$225K 0.24% 163
2018
Q3
$17M Buy
483,135
+2,427
+0.5% +$96.7K 0.27% 158
2018
Q2
$19.7M Sell
480,708
-15,202
-3% -$613K 0.32% 143
2018
Q1
$19.4M Buy
495,910
+41,226
+9% +$1.51M 0.33% 138
2017
Q4
$14.8M Buy
454,684
+15,801
+4% +$548K 0.25% 155
2017
Q3
$21M Buy
438,883
+374
+0.1% +$18.2K 0.35% 122
2017
Q2
$21.7M Buy
438,509
+140,422
+47% +$6.22M 0.37% 117
2017
Q1
$13M Sell
298,087
-4,847
-2% -$197K 0.24% 144
2016
Q4
$10M Sell
302,934
-32,337
-10% -$1.25M 0.2% 166
2016
Q3
$16.6M Buy
335,271
+54,445
+19% +$2.84M 0.31% 134
2016
Q2
$15.6M Buy
280,826
+74,842
+36% +$4.38M 0.32% 126
2016
Q1
$11.4M Buy
205,984
+168,978
+457% +$9.64M 0.25% 136
2015
Q4
$2.31M Sell
37,006
-229
-0.6% -$14.9K 0.05% 183
2015
Q3
$2.47M Buy
37,235
+724
+2% +$55.7K 0.06% 176
2015
Q2
$2.86M Sell
36,511
-911
-2% -$65.6K 0.07% 176
2015
Q1
$2.68M Buy
37,422
+872
+2% +$55.9K 0.06% 182
2014
Q4
$2.24M Buy
36,550
+4,960
+16% +$289K 0.05% 181
2014
Q3
$1.53M Buy
31,590
+11,605
+58% +$567K 0.04% 189
2014
Q2
$909K Buy
+19,985
New +$878K 0.02% 200

Other funds holding ACHC

GW&K Investment Management's ACHC Position: Q1 2026 in Review

GW&K Investment Management increased its Acadia Healthcare (ACHC) stake by 42% in Q1 2026, buying an estimated $1.89M and bringing the position to 354,966 shares worth $8.3M. The position accounts for 0.07% of the portfolio, ranked #263.

GW&K Investment Management first reported a position in ACHC in Q2 2014 and has held it in 48 quarters since. The position peaked at $92.3M in Q3 2021. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • GW&K Investment Management held 354,966 shares of Acadia Healthcare worth $8.3M as of Q1 2026.
  • GW&K Investment Management bought 104,608 Acadia Healthcare shares in Q1 2026, an estimated $1.89M.
  • Acadia Healthcare made up 0.07% of GW&K Investment Management's portfolio in Q1 2026, its #263 holding.
  • GW&K Investment Management first reported a position in Acadia Healthcare in Q2 2014 and has held it in 48 quarters since.
  • GW&K Investment Management's Acadia Healthcare position peaked at $92.3M in Q3 2021.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.